Brefeldin a induces apoptosis by activating the mitochondrial and death receptor pathways and inhibits focal adhesion kinase-mediated cell invasion

Basic and Clinical Pharmacology and Toxicology

Volumn 113, Issue 5, 2013, Pages 329-338

  Lee, Seon A ^a   Kim, Yun J ^a   Lee, Chung S ^a  

^a Chung Ang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CASPASE 3; CASPASE 8; CASPASE 9; DEATH RECEPTOR; FOCAL ADHESION KINASE; GLUTATHIONE; PROTEIN BID; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL DEATH; CELL INVASION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA FRAGMENTATION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN DEPLETION; SIGNAL TRANSDUCTION;

BOVINAE;

APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BREFELDIN A; CASPASE 8; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CYTOCHROMES C; DNA DAMAGE; DNA FRAGMENTATION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; REACTIVE OXYGEN SPECIES;

EID: 84885485589     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12107     Document Type: Article

References (39)

1. Chon HS, Hu W, Kavanagh JJ. Targeted therapies in gynecologic cancers. Curr Cancer Drug Targets 2006;6:333-63.
2. Markman B, Dienstmann R, Tabernero J. Targeting the PI3K/Akt/mTOR pathway-beyond rapalogs. Oncotarget 2010;1:530-43.
3. Peterson C. Drug therapy of cancer. Eur J Clin Pharmacol 2011;65:437-47.
4. Hu W, Kavanagh JJ. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol 2003;4:721-9.
5. Armstrong JS. Mitochondria: a target for cancer therapy. Br J Pharmacol 2006;147:239-48.
6. Camins A, Pallas M, Silvestre JS. Apoptotic mechanisms involved in neurodegenerative diseases: experimental and therapeutic approaches. Methods Find Exp Clin Pharmacol 2008;30:43-65.
7. Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther 2005;4:139-63.
8. Wallen E, Sellers RG, Peehl DM. Brefeldin A induces p53-independent apoptosis in primary cultures of human prostatic cancer cells. J Urol 2000;164(3 Pt 1):836-41.
9. Carew JS, Nawrocki ST, Krupnik YV, Dunner K Jr, McConkey DJ, Keating MJ et al. Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL. Blood 2006;107:222-31.
10. Cheung HH, Lynn Kelly N, Liston P, Korneluk RG. Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs. Exp Cell Res 2006;312:2347-57.
11. Wlodkowic D, Skommer J, Pelkonen J. Brefeldin A triggers apoptosis associated with mitochondrial breach and enhances HA14-1- and anti-Fas-mediated cell killing in follicular lymphoma cells. Leuk Res 2007;31:1687-700.
12. Egger L, Madden DT, Rhême C, Rao RV, Bredesen DE. Endoplasmic reticulum stress-induced cell death mediated by the proteasome. Cell Death Differ 2007;14:1172-80.
13. Arduino DM, Esteves AR, Domingues AF, Pereira CM, Cardoso SM, Oliveira CR. ER-mediated stress induces mitochondrial-dependent caspases activation in NT2 neuron-like cells. BMB Rep 2009;42:719-24.
14. Chipuk JE, Green DR. Dissecting p53-dependent apoptosis. Cell Death Differ 2006;13:994-1002.
15. Wiman KG. Strategies for therapeutic targeting of the p53 pathway in cancer. Cell Death Differ 2006;13:921-6.
16. Chen F, Wang W, El-Deiry WS. Current strategies to target p53 in cancer. Biochem Pharmacol 2010;80:724-30.
17. Zhivotovsky B, Orrenius S. Cell death mechanisms: cross-talk and role in disease. Exp Cell Res 2010;316:1374-83.
18. Chapman JR, Tazaki H, Mallouh C, Konno S. Mechanism of brefeldin A-induced growth inhibition and cell death in human prostatic carcinoma cells. Mol Urol 1993;3:11-6.
19. Mignotte B, Vayssière JL. Mitochondria and apoptosis. Eur J Biochem 1998;252:1-15.
20. Franco R, Cidlowski JA. Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ 2009;16:1303-14.
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
22. Andrisano V, Ballardini R, Hrelia P, Cameli N, Tosti A, Gotti R et al. Studies on the photostability and in vitro phototoxicity of Labetalol. Eur J Pharm Sci 2001;12:495-504.
23. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc Natl Acad Sci USA 1992;89:5408-12.
24. Wu H, Rao GN, Dai B, Singh P. Autocrine gastrins in colon cancer cells up-regulate cytochrome c oxidase Vb and down-regulate efflux of cytochrome c and activation of caspase-8. J Biol Chem 2000;275:32491-8.
25. Dai Y, Liu M, Tang W, Li Y, Lian J, Lawrence TS et al. A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-κB. BMC Cancer 2009;9:392.
26. Berthier A, Lemaire-Ewing S, Prunet C, Monier S, Athias A, Bessede G et al. Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ 2004;11:897-905.
27. Fu W, Luo H, Parthasarathy S, Mattson MP. Catecholamines potentiate amyloid β-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis. Neurobiol Dis 1998;5:229-43.
28. van Klaveren RJ, Hoet PHM, Pype JL, Demedts M, Nemery B. Increase in γ-glutamyltransferase by glutathione depletion in rat type II pneumocytes. Free Radic Biol Med 1997;22:525-34.
29. Borutaite V. Mitochondria as decision-makers in cell death. Environ Mol Mutagen 2010;51:406-16.
30. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis 2007;12:913-22.
31. Ramalingam M, Kim SJ. Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases. J Neural Transm 2012;119:891-910.
32. Hall AG. The role of glutathione in the regulation of apoptosis. Eur J Clin Invest 1999;29:238-45.
33. Samuni Y, Goldstein S, Dean OM, Berk M. The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta 2013;1830:4117-29.
34. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1999;84:359-69.
35. Masson-Gadais B, Houle F, Laferriere J, Huot J. Integrin avh3, requirement for VEGFR2-mediated activation of SAPK2/p38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGF. Cell Stress Chaperones 2003;8:37-52.
36. Holmes K, Roberts OL, Thomas AM, Cross MJ. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007;19:2003-12.
37. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Biochem J 2011;437:169-83.
38. van Nimwegen MJ, Verkoeijen S, van Buren L, Burg D, van de Water B. Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res 2005;65:4698-706.
39. Shen X, Li CC, Aponte AM, Shen RF, Billings EM, Moss J et al. Brefeldin A-inhibited ADP-ribosylation factor activator BIG2 regulates cell migration via integrin β1 cycling and actin remodeling. Proc Natl Acad Sci USA 2012;109:14464-9.